General
Preferred name
D-Galactose pentaacetate
Synonyms
??D-Glucose pentaacetate ()
beta-D-Glucose pentaacetate, NSC 214078 ()
β-D-Glucose pentaacetate ()
Penta-O-acetyl-β-D-glucopyranose ()
Pentaacetyl-D-galactopyranose ()
¦Â-D-Glucose pentaacetate ()
??-D-Glucose pentaacetate ()
P&D ID
PD121053
CAS
4026-35-1
604-69-3
3891-59-6
4163-60-4
4163-65-9
604-68-2
36116-83-3
25878-60-8
Tags
available
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
??-D-Glucose pentaacetate (Penta-O-acetyl-??-D-glucopyranose) is a natural product.
DESCRIPTION
D-Galactose pentaacetate inhibits leucine-induced insulin release. D-Galactose pentaacetate can be used for the research of persistent hyperinsulinemia in childhood or insulinoma[1][2].
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
4
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
Other bioactive compounds
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
64
Molecular Weight
390.12
Hydrogen Bond Acceptors
11
Hydrogen Bond Donors
0
Rotatable Bonds
6
Ring Count
1
Aromatic Ring Count
0
cLogP
-0.37
TPSA
140.73
Fraction CSP3
0.69
Chiral centers
5.0
Largest ring
6.0
QED
0.43
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
Insulin Receptor
Pathway
Protein Tyrosine Kinase/RTK
Source data
